Dasatinib in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT00474812 · COMPLETED

Trial details

NCT number: NCT00474812
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2007-05-01
Primary completion: 2013-01-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.